As show in Figure 2, hepatic fibrosis markers (COL1A1 and ACTA2) and inflammation markers (IL-β) were markedly decreased and the anti-inflammatory cytokine (IL-10) was increased in the HE group compared to in the H group. The gene discussed is ACTA2; the disease is Hepatic fibrosis.